SMTL ID : 4hjo.1

Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

monomer

Ligands

1 x AQ4: [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE(Non-covalent)

AQ4.1: 17 residues within 4Å: Chain A: L.33, V.41, A.58, K.60, L.103, T.105, Q.106, L.107, M.108, P.109, F.110, G.111, C.112, D.115, L.159, T.169, D.170 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.33, A:V.41, A:K.60, A:L.103, A:T.105, A:L.107, A:L.159, A:T.169 Hydrogen bonds: A:M.108 Water bridges: A:T.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Park, J.H. et al., Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem.J. (2012)

Release Date

2012-11-14

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence